LYFAX Mutual Fund
LYFAX Mutual Fund
AlphaCentric Life Sciences and Healthcare Fund Class A

LYFAX Mutual Fund Overview
LYFAX Mutual Fund (AlphaCentric Life Sciences and Healthcare Fund Class A) is managed by Alpha Centric Fund with $4.3M in net assets. LYFAX expense ratio is 1.71%, holding 65 positions across sectors including Health Care, Unknown, Financials. Inception date: 2019-11-29.
LYFAX performance shows a YTD return of 4.01%. The 1-year return is 24.99% and the 5-year return is 5.63%. LYFAX dividend yield stands at 1.37%, paid annually.
LYFAX top holdings include Gilead Sciences Inc (7.9%), Nvaesrtex Pharmaceuticals Inc (6.0%), Developed Markets Astrazeneca Plc Sponsored Adr (5.3%), Insmed Inc Sedol 2614487 (4.1%), Ionis Pharmaceuticals Inc (4.0%). View all LYFAX holdings, sector breakdown, or dividend history.
LYFAX can be compared against other funds using the overlap calculator or side-by-side comparison tool. LYFAX alternatives are available via the screener, along with tax-loss harvesting opportunities.